Theravance Biopharma, Inc. (TBPH)
16.38
+0.03
(+0.18%)
USD |
NASDAQ |
Apr 13, 14:38
Theravance Biopharma Price : 16.38 for April 13, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Integer Holdings Corp. | 87.45 |
| QuidelOrtho Corp. | 15.43 |
| Catalyst Pharmaceuticals, Inc. | 24.97 |
| Relmada Therapeutics, Inc. | 7.26 |
| Avalo Therapeutics, Inc. | 13.66 |
Price Related Metrics
| PE Ratio | 8.078 |
| PS Ratio | 7.827 |
| Price to Book Value | 2.843 |
| Price to Free Cash Flow | 3.527 |
| Earnings Yield | 12.38% |
| Market Cap | 843.45M |
| Normalized PE Ratio | 8.078 |